1 year return (CAGR)
-49.56%
Inovio Pharmaceuticals Inc Exchange (NASDAQ, USD)
INO
1.15
-0.01 (-0.86%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-40.63%
5 year return (CAGR)
-59.00%
10 year return (CAGR)
-36.51%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
118.91M
Price/Sales
-
Ent value
132.40M
Price/Book
27.20
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-57.37%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.17 |
| Daily high | 1.18 |
| Daily low | 1.08 |
| Daily Volume | 3.36M |
| All-time high | 2292.00 |
| 1y analyst estimate | 3.17 |
| Beta | 1.63 |
| EPS (TTM) | -0.83 |
| Dividend per share | 0.00 |
| Ex-div date | 28 Sep 2017 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| INO | S&P500 | |
| Current price drop from All-time high | -99.95% | -3.06% |
| Highest price drop | -99.97% | -56.47% |
| Date of highest drop | 30 Jul 2026 | 9 Mar 2009 |
| Avg drop from high | -92.42% | -10.68% |
| Avg time to new high | 436 days | 12 days |
| Max time to new high | 6670 days | 1805 days |
News
